Wilson Sonsini Goodrich & Rosati advised Ascidian Therapeutics on the deal.Life sciences venture capital firm ATP announced the launch of new biotechnology company Ascidian Therapeutics. ATP…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
